Fischer Medical Ventures Converts Warrants to 2.05 Cr Equity Shares, Raises ₹35.98 Cr
Fischer Medical Ventures Limited's board approved the conversion of 2,05,05,909 warrants into equity shares at ₹23.40 each. The company raised ₹35.98 crore through this conversion. Major conversions were by Mr. Shankar Varadharajan (60L warrants), FMV Holdings Pte Ltd (73.36L warrants), and Vritti Hitesh Kawa (71.70L warrants).
The conversion of warrants and subsequent fundraising can strengthen the company's financial position, potentially impacting its growth and operational capabilities.
The company successfully raised a significant amount of capital through the conversion of warrants into equity shares, which is generally a positive development.
Fischer Medical Ventures Limited announced today, August 14, 2026, the approval by its Board of Directors for the conversion of 2,05,05,909 warrants into equity shares.
These equity shares, each with a face value of Re. 1, were issued at a price of ₹23.40 per share, including a premium of ₹22.40 per share. The conversion was made for cash, with the receipt of the remaining exercise price of ₹17.55 per warrant, representing 75% of the total exercise price. This fundraising exercise aggregated to ₹35,98,78,702.95 (₹35.98 crore).
The warrants were exercised by holders belonging to both Promoter and Non-Promoter categories. Key allottees include Mr. Shankar Varadharajan (Promoter) who converted 60,00,000 warrants for ₹10,53,00,000.00, FMV Holdings Pte Ltd (Promoter) who converted 73,35,909 warrants for ₹12,87,45,202.95, and Vritti Hitesh Kawa (Non-Promoter) who converted 71,70,000 warrants for ₹12,58,33,500.00.
What to do with a filing like this
Fischer Medical Ventures Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fischer Medical Ventures Limited. Read the original for the full detail.